DexCom (DXCM) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $69.07 --0%
Revenue Growth %: +11.2%
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +11.2%
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.17, $0.02 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $696.2 million versus the consensus estimate of $700.45 million.
GUIDANCE:
DexCom sees Q3 2022 revenue of $2.86-2.91 billion, versus the consensus of $2.92 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Starts DexCom (DXCM) at Buy
- Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
